Explore RSquare BioLabs' full spectrum of testing capabilities. Click any study dropdown toggle button below to view detailed subjects, testing items, and regulatory parameters.
Subject Overview: RSquare BioLabs offers BSL-2 and BSL-3 sterile and non-sterile microbiological quality control testing tailored for pharmaceutical preparations, medical devices, water systems, and environmental monitoring. Operating under NABL ISO/IEC 17025:2017 standards, our assays comply with IP, USP, BP, and EP monographs.
Membrane filtration and direct inoculation techniques per USP <71> and IP standards in Class 100 / ISO 5 isolators.
TAMC, TYMC, and pathogen absence testing (E. coli, Salmonella, S. aureus, P. aeruginosa) per USP <61>/<62>.
Kinetic chromogenic, turbidimetric, and gel-clot LAL assays per USP <85> for parenteral drugs and medical devices.
Quantitative microbial population estimation for raw materials, in-process bulk, and non-sterile devices per ISO 11737-1.
Active air sampling, settle plates, surface swabs, and personnel glove monitoring for cleanroom validation (ISO 5, 7, 8).
Microbiological testing of Purified Water and Water for Injection including heterotrophic plate count, TOC, and conductivity.
Evaluating preservative challenge efficacy in multi-dose pharmaceutical preparations per USP <51>.
Aseptic process simulations using sterile nutrient media to validate sterile filling lines and compounding operations.
Testing preservation effectiveness in cosmetics, topical ointments, syrups, and ophthalmic drops.
Subject Overview: Comprehensive physical, chemical, potency, and stability profiling for Active Pharmaceutical Ingredients (APIs), excipients, raw materials, and finished formulations under cGMP and ICH conditions.
Subject Overview: Advanced instrument-based scientific evaluation utilizing state-of-the-art chromatography, mass spectrometry, thermal analysis, and spectroscopic instrumentation.
Subject Overview: Quality control, residue monitoring, potency evaluation, and regulatory testing for veterinary pharmaceuticals, vaccines, feed supplements, and animal health APIs.
Subject Overview: Comprehensive biological safety, chemical characterization, sterility validation, and physical strength testing for medical devices, implants, and diagnostics in accordance with ISO 10993 and CDSCO guidelines.
Subject Overview: Translational organotypic and excised viable tissue evaluation providing physiological drug permeation, organ bath contractility, biomaterial integration, and tissue-specific toxicity screening.
Subject Overview: High-throughput mammalian, primary, stem cell, and cancer cell line models for cytotoxicity, IC50 determination, gene/protein expression, apoptosis, migration, and drug screening.
Subject Overview: OECD guideline animal safety evaluations, acute/sub-chronic toxicology, pharmacokinetics (PK/PD), disease efficacy models, and implant performance studies.
Subject Overview: Quality evaluation of primary and secondary packaging materials used in pharmaceuticals and medical devices.
Subject Overview: Phytochemical marker quantification, contaminant screening, and standardization of botanical extracts and health supplements.